PPT-PSORIASIS What is Psoriasis?

Psoriasis is a chronic autoimmune skin disease that speeds up the growth cycle of skin cells Psoriasis is commonly mistaken as just a skin condition But its actually a chronic longlasting disease of the immune system. Danielle . Currey. , ND. Owner and Naturopathic Physician at Bridges Family . Wellness. www.BridgesFamilyWellness.com. About the Presenter. Dr. . Currey. has herself lived with psoriasis and psoriatic . داء الصدف. 1. Psoriasis. Psoriasis. is a chronic, non-infectious, inflammatory skin disorder, characterized by well-defined salmon pink plaques covered with large centrally attached white-scales.. Presented by:. Paige Barry . &. Chloe Janson. What is Psoriasis?. Chronic skin disease that causes a rapid growth of skin cells.. What are Symptoms of Psoriasis?. What is the Epidemiology of Psoriasis?. Press Conference. 28 October 2014. Welcome. Prof. . Myrto. . Trakatelli. Dermatologist. Miss . Dufourny. Dominique . Alderwomen of Ixelles. Prof Erwin . Tschachler. . Presentation of the Campaign. review of 51 clinically confirmed cases. Thinh Chau, Kory K. . Parsi. , Toru Ogawa, . Maija. . Kiuru. , Thomas Konia, Maxwell A. Fung . Introduction. Introduction: . Psoriasis is a common, chronic inflammatory skin disease affecting 2-3% of the US population. Although the classical histopathologic features of psoriasis have been well-documented for decades, the clinical manifestations of psoriasis are distinctive enough that the diagnosis is generally made on clinical features alone, both in routine practice and for clinical trials. Mirroring their clinical counterparts, the histopathologic features considered classical for psoriasis comprise a well-documented spectrum but have remained largely unchanged and . This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Marlee R. Steele DNP, RN, FNP-BC. Disclosures. I have no financial disclosures related to this lecture. Brand names as well as generic names are provided in the context of this talk for clarity. Learning Objectives. Click on icon. or. . From the View menu, select the Slide Show option. * . To help you as you prepare a talk, we have included the relevant text from ITC in the notes pages of each slide . . Hasan. M.B.CH.B. C.A.B.S-D.V. Psoriasis is a chronic, non-infectious, inflammatory skin disorder, characterized by well-defined . salmonpink. . plaques bearing large adherent silvery centrally attached scales.. Grupo: III-7. Dr. Alejandro . Llausas. Vargas. Culiacán, Sinaloa a 12 de Enero de 2018. DEFINICIÓN. «La psoriasis es una enfermedad cutánea hereditaria . eritematodescamativa. . Se caracteriza por lesiones bien definidas con escamas típicas blanco-nacaradas». María Carmen Ovejero-Benito, . PhD. covejero@salud.madrid.org. Clinic. . Pharmacology. . Department. Hospital Universitario de La . Princesa. Madrid (. Spain. ). Psoriasis . is. a . clinical. . heterogeneous. Menu. Quels sont les traitements ?. Cliquez ici !. Quelques conseils. Cliquez ici !. Quelles sont les complications ?. Cliquez ici !. Qu’est-ce que le psoriasis ?. Cliquez ici !. Qu’est-ce que le psoriasis ?. Tamara Arabiyat. Psoriasis is a chronic inflammatory systemic autoimmune disease.. Globally, 1-2% of the population is affected by psoriasis.. Prevalence is equal in males and females.. In monozygotic twins, if one twin has the disease, the other one has a 70% chance of being affected. In dizygotic twins, there is only a 20% chance. . Papulosquamous. . eruptionIdiopathic. , . chronicIt. is caused by thickening of the epidermis layer.. Psoriasis. Approximately 30% of patients have a family history of the same disease. believed to be inherited as Multifactorial inheritance.